One-off low-dose CT lung cancer screening in China: an appropriate strategy?
- PMID: 35276088
- DOI: 10.1016/S2213-2600(22)00047-9
One-off low-dose CT lung cancer screening in China: an appropriate strategy?
Conflict of interest statement
I am the recipient of grants from EU Horizon 2020 (4-IN-THE-LUNG-RUN; grant number 848294) and the Dutch Cancer Society (CLEARLY-TRANSCAN-FP-045). I have received fees for lung symposia organised by Merck Sharp & Dohme, Teva, Menarini, and AstraZeneca, and fees as a reviewer for Ipsos MORI, Targeted Lung Health Checks programme, England.
Comment on
-
One-off low-dose CT for lung cancer screening in China: a multicentre, population-based, prospective cohort study.Lancet Respir Med. 2022 Apr;10(4):378-391. doi: 10.1016/S2213-2600(21)00560-9. Epub 2022 Mar 8. Lancet Respir Med. 2022. PMID: 35276087
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical